VJHemOnc is committed to improving our service to you

ERIC 2020 | Developing T-cell based therapies for CLL treatment

VJHemOnc is committed to improving our service to you

Arnon Kater

Arnon Kater, MD, PhD, University of Amsterdam, Amsterdam, The Netherlands, discusses T-cell based therapy to treat chronic lymphocytic leukemia (CLL). Prof. Kater emphasizes how we can develop these therapies to improve function and that we need to set realistic goals for CLL treatment. Additionally, Prof. Kater discusses a synergistic approach of CLL targeting with both CAR T-cells and ibrutinib. However, whether the concurrent treatment of patients with both drugs really results in superior responses is still a matter of debate. This interview took place during the European Research Initiative on CLL (ERIC) International Virtual Meeting 2020.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter